Advanced search
Publication Cover
Critical Reviews in Microbiology Volume 45, 2019 - Issue 1
Submit an article Journal homepage
7,785
Views
86
CrossRef citations to date
0
Altmetric
Review Articles

Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®

Danila SeidelDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ;Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; ORCID Iconhttp://orcid.org/0000-0003-4388-3117
ORCID Icon,
Arne MeißnerDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ;Department of Hospital Hygiene and Infection Control, University Hospital Cologne, Cologne, Germany;
,
Michaela LacknerDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck (MUI), Innsbruck, Austria; ORCID Iconhttp://orcid.org/0000-0001-9073-2886
ORCID Icon,
Ellen PiepenbrockDepartment of Immunology and Hygiene, Institute for Medical Microbiology, University of Cologne, Cologne, Germany;
,
Jon Salmanton-GarcíaDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ORCID Iconhttp://orcid.org/0000-0002-6766-8297
ORCID Icon,
Melanie StecherDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ;Partner site Bonn - Cologne, German Centre for Infection Research (DZIF), Cologne, Germany;
,
Sibylle MellinghoffDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ORCID Iconhttp://orcid.org/0000-0003-3928-2503
ORCID Icon,
Axel HamprechtDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck (MUI), Innsbruck, Austria; ORCID Iconhttp://orcid.org/0000-0003-1449-5780
ORCID Icon,
Luisa Durán GraeffDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ORCID Iconhttp://orcid.org/0000-0001-5110-6356
ORCID Icon,
Philipp KöhlerDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ;Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; ;Partner site Bonn - Cologne, German Centre for Infection Research (DZIF), Cologne, Germany; ORCID Iconhttp://orcid.org/0000-0002-7386-7495
ORCID Icon,
Matthew P. ChengDivision of Infectious Diseases and Department of Medical Microbiology, McGill University Health Centre, Montreal, Canada; ORCID Iconhttp://orcid.org/0000-0002-4867-2063
ORCID Icon,
Julie DenisHôpitaux Universitaires, Department of Parasitology and Mycology, Plateau Technique de Microbiologie, FMTS, Université de Strasbourg, Strasbourg, France;
,
Isabelle ChedotalOncology and Hematology Department, University Hospital of Strasbourg and INSERM U1113, Strasbourg, France;
,
Jagdish ChanderDepartment of Microbiology, Government Medical College Hospital, Chandigarh, India;
,
Diana Lynn PakstisInfectious Diseases, Falk Medical Building, Pittsburgh, PA, USA;
,
Ibai Los-ArcosInfectious Diseases Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain; ORCID Iconhttp://orcid.org/0000-0001-8835-2702
ORCID Icon,
Monica SlavinUniversity of Melbourne, Melbourne, Australia, The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; ORCID Iconhttp://orcid.org/0000-0002-8443-314X
ORCID Icon,
Maria Teresa MontagnaDepartment of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy; ORCID Iconhttp://orcid.org/0000-0002-2958-5458
ORCID Icon,
Giuseppina CaggianoDepartment of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy; ORCID Iconhttp://orcid.org/0000-0003-3009-9147
ORCID Icon,
Mihai MaresLaboratory of Antimicrobial Chemotherapy, Ion Ionescu de la Brad University, Iași, Romania; ORCID Iconhttp://orcid.org/0000-0002-3103-4954
ORCID Icon,
Janina TrauthMedical Clinic II – Infectious Diseases, University Hospital Giessen/Marburg, Giessen, Germany;
,
Ute AurbachLaboratory Dr. Wisplinghoff, Cologne, Germany;
,
Maria J. G. T. VehreschildDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ;Partner site Bonn - Cologne, German Centre for Infection Research (DZIF), Cologne, Germany; ;Center for Integrated Oncology CIO Köln/Bonn, Medical Faculty, University of Cologne, Cologne, Germany; ORCID Iconhttp://orcid.org/0000-0002-7282-2842
ORCID Icon,
Jörg Janne VehreschildDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ;Partner site Bonn - Cologne, German Centre for Infection Research (DZIF), Cologne, Germany; ;Center for Integrated Oncology CIO Köln/Bonn, Medical Faculty, University of Cologne, Cologne, Germany; ORCID Iconhttp://orcid.org/0000-0002-5446-7170
ORCID Icon,
Rafael F. DuarteHospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain;
,
Raoul HerbrechtOncology and Hematology Department, University Hospital of Strasbourg and INSERM U1113, Strasbourg, France; ORCID Iconhttp://orcid.org/0000-0002-9381-4876
ORCID Icon,
Hilmar WisplinghoffDepartment of Immunology and Hygiene, Institute for Medical Microbiology, University of Cologne, Cologne, Germany; ;Laboratory Dr. Wisplinghoff, Cologne, Germany; ;Institute for Virology and Clinical Microbiology, Witten/Herdecke University, Witten, Germany;
&
Oliver A. CornelyDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; ;Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; ;Partner site Bonn - Cologne, German Centre for Infection Research (DZIF), Cologne, Germany; ;Center for Integrated Oncology CIO Köln/Bonn, Medical Faculty, University of Cologne, Cologne, Germany; ;Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany; ;Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-9599-3137
ORCID Icon show all
Pages 1-21 | Received 08 Jun 2018, Accepted 13 Aug 2018, Published online: 10 Jan 2019

References

  • Abela IA, Murer C, Schuurmans MM, Schmitt JW, Muller F, Imkamp F, Mueller NJ, Benden C. 2018. A cluster of scedosporiosis in lung transplant candidates and recipients: the Zurich experience and review of the literature. Transpl Infect Dis. 20:e12792.
  • Abgrall S, Pizzocolo C, Michel CB, Martinod E, Martin A, Brauner M, Padoin C, Karoubi P, Lortholary O, Bouchaud O. 2007. Scedosporium apiospermum lung infection with fatal subsequent postoperative outcome in an immunocompetent host. Clin Infect Dis. 45:524–525.
  • Agatha D, Krishnan KU, Dillirani VA, Selvi R. 2014. Invasive lung infection by Scedosporium apiospermum in an immunocompetent individual. Indian J Pathol Microbiol. 57:635–637.
  • Ahmad S, Zia S, Sarwari AR. 2010. Scedosporium prolificans endocarditis: case report and review of literature. W V Med J. 106:24–26.
  • Ahmed J, Ditmars DM, Sheppard T, del Busto R, Venkat KK, Parasuraman R. 2004. Recurrence of Scedosporium apiospermum infection following renal re-transplantation. Am J Transplant. 4:1720–1724.
  • Alastruey-Izquierdo A, Mellado E, Peláez T, Pemán J, Zapico S, Álvarez M, Rodríguez-Tudela JL, Cuenca-Estrella M. 2013. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob Agents Chemother. 57:4604.
  • Al-Jehani H, Guiot MC, Torres C, Marcoux J. 2010. Scedosporium cerebral abscesses after extra-corporeal membrane oxygenation. Can J Neurol Sci. 37:671–676.
  • Allen PB, Koka R, Kleinberg ME, Baer MR. 2013. Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report. J Clin Oncol. 31:e98–100.
  • Alpaydın S, Güler A, Çelebisoy N, Polat SH, Turhan T. 2015. Pseudallescheria boydii infection of the central nervous system: first reported case from Turkey. Acta Neurol Belg. 115:489–492.
  • Ananda-Rajah MR, Grigg A, Slavin MA. 2008. Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis. Mycopathologia. 166:83–86.
  • Anonymous. on European Medicines Agency (EMA). http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000387/human_med_001135.jsp&mid=WC0b01ac058001d124.
  • Azofra MM, Somovilla JLP, Porras MC, Carrillo LH, Pérez RD. 2010. Use of intralesional voriconazole for the treatment of cutaneous Scedosporium apiospermum infection. Clin Infect Dis. 51:255–257.
  • Balandin B, Aguilar M, Sánchez I, Monzón A, Rivera I, Salas C, Valdivia M, Alcántara S, Pérez A, Ussetti P. 2016. Scedosporium apiospermum and S. prolificans mixed disseminated infection in a lung transplant recipient: an unusual case of long-term survival with combined systemic and local antifungal therapy in intensive care unit. Med Mycol Case Rep. 11:53–56.
  • Baradkar VP, Mathur M, Kumar S. 2010. Invasive fungal sinusitis resulting in orbital apex syndrome in a HIV positive patient. Indian J Pathol Microbiol. 53:185–187.
  • Bates DD, Mims JW. 2006. Invasive fungal sinusitis caused by Pseudallescheria boydii: case report and literature review. Ear Nose Throat J. 85:729–737.
  • Baumgartner BJ, Rakita RM, Backous DD. 2007. Scedosporium apiospermum otomycosis. Am J Otolaryngol. 28:254–256.
  • Beier F, Kittan N, Holzmann T, Schardt K, Andreesen R, Holler E, Hildebrandt GC. 2010. Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia. Transpl Infect Dis. 12:538–542.
  • Bhat SV, Paterson DL, Rinaldi MG, Veldkamp PJ. 2007. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand J Infect Dis. 39:87–90.
  • Bhatk V, Naseeruddin K. 2001. Invasive sino-nasal pseudallescheriasis in a non-immunocompromised patient. Indian J Otolaryngol Head Neck Surg. 53:148–150.
  • Bibashi E, de Hoog GS, Kostopoulou E, Tsivitanidou M, Sevastidou J, Geleris P. 2009. Invasive infection caused by Pseudallescheria boydii in an immunocompetent patient. Hippokratia. 13:184–186.
  • Biswas C, Law D, Birch M, Halliday C, Sorrell TC, Rex J, Slavin M, Chen SC. 2018. In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi. Med Mycol. 1–5. doi:10.1093/mmy/myx161. [Epub ahead of print].
  • Blyth CC, Gilroy NM, Guy SD, Chambers ST, Cheong EY, Gottlieb T, McGuinness SL, Thursky KA. 2014. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J. 44:1333–1349.
  • Bose B, Sharma S, Derrington P, Divi D. 2012. Scedosporium apiospermum peritonitis in a patient undergoing peritoneal dialysis. Nephrology (Carlton).17:521–522.
  • Bosma F, Voss A, van Hamersvelt HW, de Sévaux RG, Biert J, Kullberg BJ, Melchers WG, Verweij PE. 2003. Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole. Clin Microbiol Infect. 9:750–753.
  • Bouza E, Muñoz P. 2004. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin Microbiol Infect. 10:76–85.
  • Boyce Z, Collins N. 2015. Scedosporium apiospermum: an unreported cause of fungal sporotrichoid-like lymphocutaneous infection in Australia and review of the literature. Australas J Dermatol. 56:e39–e42.
  • Bui DK, Carvounis PE. 2016. Favorable outcomes of filamentous fungal endophthalmitis following aggressive management. J Ocul Pharmacol Ther. 32:623–630.
  • Buzina W, Feierl G, Haas D, Reinthaler FF, Holl A, Kleinert R, Reichenpfader B, Roll P, Marth E. 2006. Lethal brain abscess due to the fungus Scedosporium apiospermum (teleomorph Pseudallescheria boydii) after a near-drowning incident: case report and review of the literature. Med Mycol. 44:473–477.
  • Caira M, Girmenia C, Valentini CG, Sanguinetti M, Bonini A, Rossi G, Fianchi L, Leone G, Pagano L. 2008. Scedosporiosis in patients with acute leukemia: a retrospective multicenter report. Haematologica. 93:104–110.
  • Campagnaro EL, Woodside KJ, Early MG, Gugliuzza KK, Colomé-Grimmer MI, Lopez FA, Daller JA. 2002. Disseminated Pseudallescheria boydii (Scedosporium apiospermum) infection in a renal transplant patient. Transpl Infect Dis. 4:207–211.
  • Campa-Thompson MM, West JA, Guileyardo JM, Spak CW, Sloan LM, Beal SG. 2014. Clinical and morphologic findings in disseminated Scedosporium apiospermum infections in immunocompromised patients. Proc (Bayl Univ Med Cent). 27:253–256.
  • Canet JJ, Pagerols X, Sánchez C, Vives P, Garau J. 2001. Lymphocutaneous syndrome due to Scedosporium apiospermum. Clin Microbiol Infect. 7:648–650.
  • Cardoso JC, Serra D, Cardoso R, Reis JP, Tellechea O, Figueiredo A. 2009. Cutaneous pseudallescheria boydii infection in a renal transplant patient: a case report. Dermatol Online J. 15:8.
  • Carod-Artal FJ, Ferreira-Coral L, Mauro-Couto J, Gomes E, de Agassiz-Vasques M. 2009. Chronic spinal epidural abscess caused by Scedosporium prolificans in an immunocompetent patient. Spine (Phila Pa 1976). 34:E330–E332.
  • Carrillo AJ, Guarro J. 2001. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother. 45:2151–2153.
  • Castanheira M, Duncanson FP, Diekema DJ, Guarro J, Jones RN, Pfaller MA. 2012. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods. Antimicrob Agents Chemother. 56:352–357.
  • Ceccarelli L, Calisti G, Delle Rose D, Ricciardi A, Maffongelli G, Sordillo P, Sarmati L, Andreoni M. 2012. Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. Infection. 40:459–462.
  • Cetrulo CL, Jr., Leto Barone AA, Jordan K, Chang DS, Louie K, Buntic RF, Brooks D. 2012. A multi-disciplinary approach to the management of fungal osteomyelitis: current concepts in post-traumatic lower extremity reconstruction: a case report. Microsurgery. 32:144–147.
  • Chanqueo L, Gutiérrez C, Tapia C, Silva V, Razeto L, Misad C. 2009. [Scedosporium apiospermum rhinosinusal infection in an immunocompetent host]. Rev Chil Infectol. 26:453–456.
  • Chaveiro MA, Vieira R, Cardoso J, Afonso A. 2003. Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient. J Eur Acad Dermatol Venerol. 17:47–49.
  • Chen FK, Chen SD, Tay-Kearney ML. 2007. Intravitreal voriconazole for the treatment of endogenous endophthalmitis caused by Scedosporium apiospermum. Clin Experiment Ophthalmol. 35:382–385.
  • Chen TC, Ho MW, Chien WC, Lin HH. 2016. Disseminated Scedosporium apiospermum infection in a near-drowning patient. J Formos Med Assoc.115:213–214.
  • Clement ME, Maziarz EK, Schroder JN, Patel CB, Perfect JR. 2015. Scedosporium apiosermum infection of the "Native" valve: Fungal endocarditis in an orthotopic heart transplant recipient. Med Mycol Case Rep. 9:34–36.
  • clinicaltrials.gov. 2017. Amplyx Pharmaceuticals. Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia; NCT03333005. [accessed 2018 Apr 18]. https://clinicaltrials.gov/ct2/show/NCT03333005?term=APX001&rank =1.
  • Cooley L, Spelman D, Thursky K, Slavin M. 2007. Infection with Scedosporium apiospermum and S. prolificans, Australia. Emerging Infect Dis. 13:1170–1177.
  • Cruz R, Barros M, Reyes M. 2015. [Pulmonary non invasive infection by Scedosporium apiospermum]. Rev Chilena Infectol. 32:472–475.
  • Cuenca-Estrella M, Ruiz-Díez B, Martínez-Suárez JV, Monzón A, Rodríguez-Tudela JL. 1999. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother. 43:149–151.
  • Danaher PJ, Walter EA. 2004. Successful treatment of chronic meningitis caused by Scedosporium apiospermum with oral voriconazole. Mayo Clin Proc. 79:707–708.
  • Daniele L, Le M, Parr AF, Brown LM. 2017. Scedosporium prolificans septic arthritis and osteomyelitis of the hip joints in an immunocompetent patient: a case report and literature review. Case Rep Orthop. 2017:1–3809735.
  • De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 46:1813–1821.
  • Denton EJ, Smibert O, Gooi J, Morrissey CO, Snell G, McGiffin D, Paraskeva M. 2016. Invasive Scedosporium sternal osteomyelitis following lung transplant: Cured. Med Mycol Case Rep. 12:14–16.
  • D'Hondt K, Parys-Van Ginderdeuren R, Foets B. 2000. Fungal keratitis caused by Pseudallescheria boydii (Scedosporium apiospermum). Bull Soc Belge Ophtalmol. 277:53–56.
  • Douglas AP, Chen SC, Slavin MA. 2016. Emerging infections caused by non-Aspergillus filamentous fungi. Clin Microbiol Infect. 22:670–680.
  • Elm MK, Ahmed A, Goksel D, Henning JS. 2009. Cutaneous and systemic infection with Scedosporium apiospermum. Cutis. 84:275–278.
  • Ergin C, Kutlu M, Arıkan Akdağlı S, Sarıbaş Z, Aydeniz Ozansoy F, Sarı I, Dursunoğlu N. 2013. [Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient]. Mikrobiyol Bul. 47:351–355.
  • Espinel-Ingroff A. 2001. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol. 39:954–958.
  • Ezzedine K, Wissing KM, Jacobs F, Rodríguez H, Malvy D, Simonart T. 2009. Recurrent Scedosporium apiospermum skin infection in a renal transplant recipient. J Eur Acad Dermatol Venereol. 23:95–96.
  • Fadzillah MT, Ishak SR, Ibrahim M. 2013. Refractory Scedosporium apiospermum keratitis successfully treated with combination of Amphotericin B and Voriconazole. Case Rep Ophthalmol Med. 2013:413953.
  • Farina C, Arosio M, Marchesi G, Amer M. 2002. Scedosporium apiospermum post-traumatic cranial infection. Brain Inj. 16:627–631.
  • Farina C, Gotti E, Suter F, Goglio A. 2006. Scedosporium apiospermum soft-tissue infection: a case report and review of kidney transplant literature. Transplant Proc. 38:1333–1335.
  • Fernández Guerrero ML, Askari E, Prieto E, Gadea I, Roman A. 2011. Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity. Eur J Clin Microbiol Infect Dis. 30:1321–1324.
  • Fernández-Mosteirín N, Salvador-Osuna C, Mayayo P, García-Zueco JC. 2003. [Scedosporium prolificans: disseminated infection in immunocompromised patient]. Med Clin (Barc). 120:317–318.
  • Fietz T, Knauf W, Schwartz S, Thiel E. 2003. Intramedullary abscess in a patient with disseminated Scedosporium apiospermum infection. Br J Haematol. 120:724.
  • Figueroa MS, Fortun J, Clement A, De Arévalo BF. 2004. Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole. Retina. 24:319–320.
  • Foo H, Ooi SY, Giles R, Jones P. 2009. Scedosporium apiospermum pacemaker endocarditis. Int J Cardiol. 131:e81–e82.
  • García-Vidal C, Cabellos C, Ayats J, Font F, Ferran E, Fernández-Viladrich P. 2009. Fungal postoperative spondylodiscitis due to Scedosporium prolificans. Spine J. 9:e1–e7.
  • Gelabert-González M, Llovo-Taboada J, Reyes-Santías R, Arcos-Algaba A, Serramito-García R, Peñalver-Barral MD, García-Allut A. 2010. [Scedosporium apiospermum brain abscess. Report of one case with literature review]. Neurocirugia (Astur). 21:125–131.
  • German JW, Kellie SM, Pai MP, Turner PT. 2004. Treatment of a chronic Scedosporium apiospermum vertebral osteomyelitis. Case report. Neurosurg Focus. 17:E9.
  • Ghosh R, Mishra P, Maiti PK, Debnandi A. 2017. Prompt diagnosis of Scedosporium apiospermum soft tissue infection: Life-saving in a renal transplant recipient. J Postgrad Med. 63:200–202.
  • Goldman C, Akiyama MJ, Torres J, Louie E, Meehan SA. 2016. Scedosporium apiospermum infections and the role of combination antifungal therapy and GM-CSF: A case report and review of the literature. Med Mycol Case Rep. 11:40–43.
  • Gosbell IB, Toumasatos V, Yong J, Kuo RS, Ellis DH, Perrie RC. 2003. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses. 46:233–236.
  • Gottesman-Yekutieli T, Shwartz O, Edelman A, Hendel D, Dan M. 2011. Pseudallescheria boydii infection of a prosthetic hip joint – an uncommon infection in a rare location. Amer J Med Sci. 342:250–253.
  • Greig JR, Khan MA, Hopkinson NS, Marshall BG, Wilson PO, Rahman SU. 2001. Pulmonary infection with Scedosporium prolificans in an immunocompetent individual. J Infect. 43:15–17.
  • Grenouillet F, Botterel F, Crouzet J, Larosa F, Hicheri Y, Forel JM, Helias P, Ranque S, Delhaes L. 2009. Scedosporium prolificans: an emerging pathogen in France? Med Mycol. 47:343–350.
  • Guarro J, Kantarcioglu AS, Horré R, Rodríguez-Tudela JL, Cuenca Estrella M, Berenguer J, de Hoog GS. 2006. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol. 44:295–327.
  • Guber I, Bergin C, Majo F. 2016. Repeated intrastromal injections of voriconazole in combination with corneal debridement for recalcitrant Fungal Keratitis – a case series. Klin Monbl Augenheilkd. 233:369–372.
  • Guignard S, Hubert D, Dupont B, Anract P, Alioua D, Guerini H, Paugam A, Dougados M. 2008. Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient. J Cyst Fibros. 7:89–91.
  • Harrison MK, Hiatt KH, Smoller BR, Cheung WL. 2012. A case of cutaneous Scedosporium infection in an immunocompromised patient. J Cutan Pathol. 39:458–460.
  • He XH, Wu JY, Wu CJ, Halm-Lutterodt NV, Zhang J, Li CS. 2015. Scedosporium apiospermum Infection after Near-drowning. Chin Med J. 128:2119–2123.
  • Henao-Martínez AF, Castillo-Mancilla JR, Barron MA, Nichol AC. 2013. Combination antifungal therapy in the treatment of scedosporium apiospermum central nervous system infections. Case Rep Infect Dis. 2013:589490.
  • Holmes NE, Trevillyan JM, Kidd SE, Leong TY. 2013. Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma. Med Mycol Case Rep. 2:98–102.
  • Horré R, Feil E, Stangel AP, Zhou H, Gilges S, Wöhrmann A, de Hoog GS, Meis JF, Marklein G, Schaal KP. 2000. [Scedosporiosis of the brain with fatal outcome after traumatizatio of the foot. case report]. Mycoses. 43:33–36.
  • Horré R, Jovanic B, Marklein G, Schumacher G, Friedrichs N, Neuhaus T, de Hoog GS, Becker WH, Choi SM, Schaal KP. 2003. Fatal pulmonary scedosporiosis. Mycoses. 46:418–421.
  • Horré R, Marklein G. 2009. Isolation and clinical significance of Pseudallescheria and Scedosporium species. Med Mycol. 47:415–421.
  • Howden BP, Slavin MA, Schwarer AP, Mijch AM. 2003. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis. 22:111–113.
  • Hu H, Chen J. 2017. Scedosporiosis presenting with subcutaneous nodules in an immunocompromised patient. Indian J Dermatol Venereol Leprol. 83:71–73.
  • Husain N, Chen TC, Hou JK. 2013. An unusual cause of diarrhea in an immunocompromised patient. Scedosporium apiospermum Colitis and Brain Abscess. Gastroenterology.145(3):519, 697–698.
  • Husain S, Muñoz P, Forrest G, Alexander BD, Somani J, Brennan K, Wagener MM, Singh N. 2005. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis. 40:89–99.
  • Global Soil Data Task. 2014. Global Soil Data Products CD-ROM Contents (IGBP-DIS). Oak Ridge, Tennessee: ORNL DAAC. [accessed 2018 Apr 11]. https://doi.org/10.3334/ORNLDAAC/565.
  • Ikewaki J, Imaizumi M, Nakamuro T, Motomura Y, Ohkusu K, Shinoda K, Nakatsuka K. 2009. Peribulbar fungal abscess and endophthalmitis following posterior subtenon injection of triamcinolone acetonide. Acta Ophthalmol. 87:102–104.
  • Institute CaLaS. (2008). Clinical and Laboratory and Standards Institute 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. 2nd ed. Wayne, PA: Clinical and Laboratory and Standards Institute.
  • Ishii S, Hiruma M, Hayakawa Y, Sugita T, Makimura K, Hiruma M, Yoshiike T. 2015. Cutaneous Pseudallescheria boydii/Scedosporium apiospermum Complex (Molecular type: Scedosporium apiospermum [Clade 4]) infection: a case report and literature review of cases from Japan. Med Mycol J. 56:E25–E30.
  • Jain A, Egbert P, McCulley TJ, Blumenkranz MS, Moshfeghi DM. 2007. Endogenous Scedosporium apiospermum endophthalmitis. Arch Ophthalmol. 125:1286–1289.
  • Jain P, Nagarajan P, Prayag P, Benton CB, Kadia T, Groisberg R, Kontoyiannis DP, Mulanovich VE, Pemmaraju N. 2017. Mixed angioinvasive exserohilum and scedosporium infection in a patient with AML. Am J Hematol. 92:119–120.
  • Kaltseis J, Rainer J, De Hoog GS. 2009. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med Mycol. 47:398–405.
  • Kanafani ZA, Comair Y, Kanj SS. 2004. Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review. Eur J Clin Microbiol Infect Dis. 23:836–840.
  • Kantarcioglu AS, Guarro J, de Hoog GS. 2008. Central nervous system infections by members of the Pseudallescheria boydii species complex in healthy and immunocompromised hosts: epidemiology, clinical characteristics and outcome. Mycoses. 51:275–290.
  • Katragkou A, Dotis J, Kotsiou M, Tamiolaki M, Roilides E. 2007. Scedosporium apiospermum infection after near-drowning. Mycoses. 50:412–421.
  • Kelly M, Stevens R, Konecny P. 2016. Lomentospora prolificans endocarditis-case report and literature review. BMC Infect Dis. 16:36.
  • Kepez Yildiz B, Hasanreisoglu M, Aktas Z, Aksu G, Kocak BC, Akata F. 2014. Fungal keratitis secondary to Scedosporium apiospermum infection and successful treatment with surgical and medical intervention. Int Ophthalmol. 34:305–308.
  • Kim CM, Lim SC, Kim J, Jang HS, Chung JH, Yun NR, Kim DM, Jha P, Jha B, Kim SW, et al. 2017. Tenosynovitis caused by Scedosporium apiospermum infection misdiagnosed as an Alternaria species: a case report. BMC Infect Dis. 17:72.
  • Kim SH, Ha YE, Youn JC, Park JS, Sung H, Kim MN, Choi HJ, Lee YJ, Kang SM, Ahn JY, et al. 2015. Fatal scedosporiosis in multiple solid organ allografts transmitted from a nearly-drowned donor. Am J Transplant. 15:833–840.
  • Kimura M, Maenishi O, Ito H, Ohkusu K. 2010. Unique histological characteristics of Scedosporium that could aid in its identification. Pathol Int. 60:131–136.
  • Kiraz N, Gülbas Z, Akgün Y, Uzun O. 2001. Lymphadenitis caused by Scedosporium apiospermum in an immunocompetent patient. Clin Infect Dis. 32:E59–E61.
  • Kite BW, Heng T. 2016. An atypical foot infection. Aust Fam Physician. 45:819–820.
  • Kooijman CM, Kampinga GA, de Hoog GS, Goudswaard WB, Reijnen MM. 2007. Successful treatment of Scedosporium aurantiacum osteomyelitis in an immunocompetent patient. Surg Infect (Larchmt). 8:605–610.
  • Kowacs PA, Soares Silvado CE, Monteiro de Almeida S, Ramos M, Abrao K, Madaloso LE, Pinheiro RL, Werneck LC. 2004. Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factors. J Clin Pathol. 57:205–207.
  • Kubisiak-Rzepczyk H, Gil L, Zawirska A, Kubisiak-Michalska A, Mol A, Reich A, Komarnicki M, Adamski Z. 2013. Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia. J Mycol Med. 23:261–264.
  • Lackner M, de Hoog G, Yang L, Ferreira Moreno L, Ahmed S, Andreas F, Kaltseis J, Nagl M, Lass-Flörl C, Risslegger B, et al. 2014. Proposed nomenclature for Pseudallescheria, Scedosporium and related genera. Fungal Diversity. 67:1–10.
  • Lackner M, De Man FH, Eygendaal D, Wintermans RGF, Kluytmans JA, Klaassen CH, Meis JF. 2011. Severe prosthetic joint infection in an immunocompetent male patient due to a therapy refractory Pseudallescheria apiosperma. Mycoses. 54:22–27.
  • Lackner M, Fernandez-Silva F, Guarro J, Lass-Florl C. 2014. Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii. J Antimicrob Chemother. 69:3027–3032.
  • Lahmer T, Messer M, Ehmer U, Eser S, Beitz A, Fekecs L, Schmid RM, Huber W. 2016. Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a critically ill hematopoietic stem cell recipient with ARDS. Mycopathologia. 181:267–271.
  • Lainscak M, Hocevar A, Logar D, Beović B, Matos T, Tomsic M. 2007. Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient. Clin Rheumatol. 26:1023–1024.
  • Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. 2006. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989–2006. Clin Infect Dis. 43:1580–1584.
  • Larbcharoensub N, Chongtrakool P, Wirojtananugoon C, Watcharananan SP, Sumethkul V, Boongird A, Jirasiritham S. 2013. Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient. Southeast Asian J Trop Med Public Health. 44:484–489.
  • Larocco A, Jr, Barron JB. 2005. Endogenous scedosporium apiospermum endophthalmitis. Retina. 25:1090–1093.
  • Lass-Flörl C, Cuenca-Estrella M. 2017. Changes in the epidemiological landscape of invasive mould infections and disease. J Antimicrob Chemother. 72:i5–i11.
  • Lavy D, Morin O, Venet G, Maugars Y, Prost A, Berthelot JM. 2001. Pseudallescheria boydii knee arthritis in a young immunocompetent adult two years after a compound patellar fracture. Joint Bone Spine. 68:517–520.
  • Leck A, Matheson M, Tuft S, Waheed K, Lagonowski H. 2003. Scedosporium apiospermum keratomycosis with secondary endophthalmitis. Eye (Lond). 17:841–843.
  • Leechawengwongs M, Milindankura S, Liengudom A, Chanakul K, Viranuvatti K, Clongsusuek P. 2007. Multiple Scedosporium apiospermum brain abscesses after near-drowning successfully treated with surgery and long-term voriconazole: a case report. Mycoses. 50:512–516.
  • Leek R, Aldag E, Nadeem I, Gunabushanam V, Sahajpal A, Kramer DJ, Walsh TJ. 2016. Scedosporiosis in a combined kidney and liver transplant recipient: a case report of possible transmission from a near-drowning donor. Case Rep Transplant. 2016:1.
  • Levine NB, Kurokawa R, Fichtenbaum CJ, Howington JA, Kuntz C. 2002. An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis. J Spinal Disord Tech. 15:425–430.
  • Li JY, Yong TY, Grove DI, Coates PT. 2008. Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient. Transplant Infect Dis. 10:63–65.
  • Lin D, Kamili Q, Qurat-Ul-Ain K, Lai S, Musher DM, Hamill R. 2013. Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations. Infection. 41:723–726.
  • Luijk B, Ekkelenkamp MB, De Jong PA, Kwakkel-van Erp JM, Grutters JC, van Kessel DA, van de Graaf EA. 2011. Effective prolonged therapy with voriconazole in a lung transplant recipient with spondylodiscitis induced by scedosporium apiospermum. Case Rep Infect Dis. 2011:1.
  • Luu KK, Scott IU, Miller D, Davis JL. 2001. Endogenous Pseudallescheria boydii endophthalmitis in a patient with ring-enhancing brain lesions. Ophthalmic Surg Lasers. 32:325–329.
  • Makino K, Fukushima S, Maruo K, Egawa K, Nishimoto K, Ihn H. 2011. Cutaneous hyalohyphomycosis by Scedosporium apiospermum in an immunocompromised patient. Mycoses. 54:259–261.
  • Masukane S, Kitahara Y, Okumoto J, Sasaki K, Nakano K. 2017. The effective treatment of lung infection due to Scedosporium prolificans with voriconazole and surgery. Intern Med. 56:973–977.
  • Matsumoto Y, Oh IT, Nagai A, Ohyama F, Ooishi T, Tsuboi R. 2009. Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole. J Dermatol. 36:98–102.
  • Mays R, Gordon R, Wilson JM, LaPolla WJ, Sra KK, Madkan V, Tyring SK. 2012. Persistent erythematous plaque after minor trauma in an immunocompromised woman. Dermatol Online J. 18:2.
  • McCarthy MW, Kontoyiannis DP, Cornely OA, Perfect JR, Walsh TJ. 2017. Novel agents and drug targets to meet the challenges of resistant fungi. J Infect Dis. 216:S474–S483.
  • Mei Y, Chen X, Sun K, Lv J, Sun H, Zhang J. 2018. Scedosporium apiospermum infection: lethal complication after extracorporeal cardiopulmonary resuscitation. Perfusion. 33(1):71–73.
  • Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE, Network E. 2002. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother. 46:62–68.
  • Meletiadis J, Mouton JW, Meis JF, Verweij PE. 2003. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother. 47:106–117.
  • Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ. 2002. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis. 34:1648–1650.
  • Mesfin FB, Tobin E, Adamo MA, DiRisio D. 2008. Fungal vertebral osteomyelitis due to Scedosporium apiospermum after near-drowning – Case report. J Neurosurg Spine. 9:58–61.
  • Miele PS, Levy CS, Smith MA, Dugan EM, Cooke RH, Light JA, Lucey DR. 2002. Primary cutaneous fungal infections in solid organ transplantation: a case series. Am J Transplant. 2:678–683.
  • Mohan R, Gopakumar TS. 2016. Clinico-radiological improvement in an immunocompetent patient presented with scedosporium apiospermum osteomyelitis. J Clin Orthop Trauma. 7:134–137.
  • Moloney TP, Park J. 2014. Pseudallescheria endophthalmitis: four cases over 15 years in Queensland, Australia, and a review of the literature. Retina. 34:1683–1701.
  • Morales P, Galán G, Sanmartín E, Monte E, Tarrazona V, Santos M. 2009. Intrabronchial instillation of amphotericin B lipid complex: a case report. Transplant Proc. 41:2223–2224.
  • Morio F, Horeau-Langlard D, Gay-Andrieu F, Talarmin JP, Haloun A, Treilhaud M, Despins P, Jossic F, Nourry L, Danner-Boucher I, et al. 2010. Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. J Clin Microbiol. 48:1978–1982.
  • Mügge T, Schömig E. 2017. Jahresabschluss 2016, on Uniklinik Köln. [accessed 2017 Nov 01]. https://www.uk-koeln.de/uniklinik-koeln/die-uniklinik/jahres-qualitaetsberichte/.
  • Muñoz P, Marín M, Tornero P, Martín Rabadán P, Rodríguez-Creixems M, Bouza E. 2000. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis. 31:1499–1501.
  • Musk M, Chambers D, Chin W, Murray R, Gabbay E. 2006. Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management. J Heart Lung Transplant. 25:1268–1272.
  • Nakamura Y, Suzuki N, Nakajima Y, Utsumi Y, Murata O, Nagashima H, Saito H, Sasaki N, Fujimura I, Ogino Y, et al. 2013. Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan. Respir Investig. 51:207–211.
  • Nakamura Y, Utsumi Y, Suzuki N, Nakajima Y, Murata O, Sasaki N, Nitanai H, Nagashima H, Miyamoto S, Yaegashi J, et al. 2011. Multiple Scedosporium apiospermum abscesses in a woman survivor of a tsunami in northeastern Japan: a case report. J Med Case Reports. 5:526.
  • Ngai JC, Lam R, Ko FW, To KW, Hui DS. 2009. Pulmonary scedosporium infection as a complication of infliximab therapy for ankylosing spondylitis. Thorax. 64:184–184.
  • Nguyen BD. 2001. Pseudallescheriasis of the lung and central nervous system: multimodality imaging. AJR Am J Roentgenol. 176:257–258.
  • Nguyen CT, Raychaudhuri SP. 2011. Scedosporium infection in a patient with anti-tnfα therapy. Indian J Dermatol. 56:82–83.
  • Nishimori M, Takahashi T, Suzuki E, Kodaka T, Hiramoto N, Itoh K, Tsunemine H, Yarita K, Kamei K, Takegawa H, et al. 2014. Fatal fungemia with Scedosporium prolificans in a patient with acute myeloid leukemia. Med Mycol J. 55:E63–E70.
  • Nochez Y, Arsene S, Le Guellec C, Bastides F, Morange V, Chaumais MC, Pisella PJ. 2008. Unusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitis. J Ocul Pharmacol Ther. 24:87–90.
  • Nulens E, Eggink C, Rijs AJ, Wesseling P, Verweij PE. 2003. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J Clin Microbiol. 41:2261–2264.
  • O'Bryan TA, Browne FA, Schonder JF. 2002. Scedosporium apiospermum (Pseudallescheria boydii) endocarditis. J Infect. 44:189–192.
  • O'Bryan TA. 2005. Pseudallescheriasis in the 21st century. Expert Rev anti Infect Ther. 3:765–773.
  • Ochi Y, Hiramoto N, Takegawa H, Yonetani N, Doi A, Ichikawa C, Imai Y, Ishikawa T. 2015. Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy. Int J Hematol. 101:620–625.
  • Ochiai N, Shimazaki C, Uchida R, Fuchida S, Okano A, Ashihara E, Inaba T, Fujita N, Nakagawa M. 2003. Disseminated infection due to Scedosporium apiospermum in a patient with acute myelogenous leukemia. Leuk Lymphoma. 44:369–372.
  • O'Doherty M, Hannan M, Fulcher T. 2005. Voriconazole in the treatment of fungal osteomyelitis of the orbit in the immunocompromised host. Orbit. 24:285–289.
  • Ogawa Y, Sato M, Tashiro M, Miyazaki M, Nagata K, Takahashi N, Kasahara K, Izumikawa K, Yano H, Mikasa K. 2016. Rapid development of a mycotic aneurysm of the intracranial artery secondary to Scedosporium apiospermum sinusitis. Med Mycol Case Rep. 14:30–32.
  • Oh IK, Baek S, Huh K, Oh J. 2007. Periocular abscess caused by Pseudallescheria boydii after a posterior subtenon injection of triamcinolone acetonide. Graefes Arch Clin Exp Ophthalmol. 245:164–166.
  • Ohashi R, Kato M, Katsura Y, Takekawa H, Hoshika Y, Sugawara T, Yoshimi K, Togo S, Nagaoka T, Seyama K, et al. 2011. Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS). Med Mycol J. 52:33–38.
  • O’Hearn TM, Geiseler PJ, Bhatti RA, Eliott D. 2010. Control of disseminated scedosporium prolificans infection and endophthalmitis. Retin Cases Brief Rep. 4:18–19.
  • Oliver JD, Sibley GE, Beckmann N, Dobb KS, Slater MJ, McEntee L, du Pre S, Livermore J, Bromley MJ, Wiederhold NP, et al. 2016. F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proc Natl Acad Sci USA. 113(45):12809–12814.
  • Ong A, Blyth CC, Bency R, Vicaretti M, Harun A, Meyer W, Shingde M, Gilroy N, Chapman J, Chen SCA. 2011. Fatal mycotic aneurysms due to Scedosporium and Pseudallescheria infection. J Clin Microbiol. 49:2067–2071.
  • Ortmann C, Wüllenweber J, Brinkmann B, Fracasso T. 2010. Fatal mycotic aneurysm caused by Pseudallescheria boydii after near drowning. Int J Legal Med. 124:243–247.
  • Panackal AA, Marr KA. 2004. Scedosporium/Pseudallescheria infections. Semin Respir Crit Care Med. 25:171–181.
  • Patel MS, Wright AJ, Kohn R, Markmann JF, Kotton CN, Vagefi PA. 2015. Successful long-term management of invasive cerebral fungal infection following liver transplantation. Mycoses. 58:181–186.
  • Patel R, Orlandi RR. 2015. Fungal septal abscess complicating maxillary sinus fungus balls in an immunocompetent host. Allergy Rhinol (Providence). 6:184–187.
  • Patterson TF, Thompson GR, 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, et al. 2016. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 63:433–e60.
  • Pellón Dabén R, Marco de Lucas E, Martín Cuesta L, Piedra Velasco T, Arnaiz García J, Landeras R, López Duarte M, Bermúdez A. 2007. Imaging findings of pulmonary infection caused by Scedosporium prolificans in a deep immunocompromised patient. Emerg Radiol. 15:47–49.
  • Pennekamp PH, Diedrich O, Zhou H, Kraft CN. 2003. [Foot injury as a rare cause of scendosporiosis with fetal outcome]. Unfallchirurg. 106:865–868.
  • Perlroth MG, Miller J. 2004. Pseudoallescheria boydii pneumonia and empyema: a rare complication of heart transplantation cured with voriconazole. J Heart Lung Transplant. 23:647–649.
  • Porte L, Khatibi S, Hajj LE, Cassaing S, Berry A, Massip P, Linas MD, Magnaval JF, Sans N, Marchou B. 2006. Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. Trans R Soc Trop Med Hyg. 100:891–894.
  • Posteraro P, Frances C, Didona B, Dorent R, Posteraro B, Fadda G. 2003. Persistent subcutaneous Scedosporium apiospermum infection. Eur J Dermatol. 13:603–605.
  • Raj R, Frost AE. 2002. Scedosporium apiospermum fungemia in a lung transplant recipient. Chest. 121:1714–1716.
  • Reimann D, Büssemaker E, Gross P. 2004. Successful treatment due to vacuum seal technique of a severe Scedosporium apiospermum skin infection in a renal transplant recipient. Nephrol Dial Transplant. 19:245–248.
  • Riddell J, Chenoweth CE, Kauffman CA. 2004. Disseminated Scedosporium apiospermum infection in a previously healthy woman with HELLP syndrome. Mycoses. 47:442–446.
  • Rivier A, Perny J, Debourgogne A, Thivillier C, Lévy B, Gérard A, Machouart M. 2011. Fatal disseminated infection due to Scedosporium prolificans in a patient with acute myeloid leukemia and posaconazole prophylaxis. Leukemia Lymphoma. 52:1607–1610.
  • Rodriguez MM, Calvo E, Serena C, Marine M, Pastor FJ, Guarro J. 2009. Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Antimicrob Agents Chemother. 53:2153–2155.
  • Rodríguez-Tudela JL, Berenguer J, Guarro J, Kantarcioglu AS, Horré R, de Hoog GS, Cuenca-Estrella M. 2009. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol. 47:359–370.
  • Rogasi PG, Zanazzi M, Nocentini J, Fantoni E, Trotta M, Faggi E, Fontanelli A, Bertoni E, Salvadori M, Leoncini F. 2007. Disseminated Scedosporium apiospermum infection in renal transplant recipient: long-term successful treatment with voriconazole: a case report. Transplant Proc. 39:2033–2035.
  • Roy R, Panigrahi PK, Pal SS, Mukherjee A, Bhargava M. 2016. Post-traumatic endophthalmitis secondary to keratomycosis caused by scedosporium apiospermum. Ocul Immunol Inflamm. 24:107–109.
  • Ruinemans GM, Haagsma CJ, Hendrix R. 2011. Tenosynovitis caused by a pseudallescheria boydii infection and symptoms of reflex sympathetic dystrophy after a dog bite. J Clin Rheumatol. 17:363–364.
  • Ryder NS, Leitner I. 2001. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol. 39:91–95.
  • Safdar A, Papadopoulos EB, Young JW. 2002. Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy. Transpl Infect Dis. 4:212–217.
  • Sahi H, Avery RK, Minai OA, Hall G, Mehta AC, Raina P, Budev M. 2007. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant. 26:350–356.
  • Saracli MA, Erdem U, Gonlum A, Yildiran ST. 2003. Scedosporium apiospermum keratitis treated with itraconazole. Med Mycol. 41:111–114.
  • Sarva ST, Manjunath SK, Baldwin HS, Robins DB, Freire AX. 2010. Lung scedosporiosis in human immunodeficiency virus/acquired immunodeficiency syndrome. Am J Med Sci. 339:300–303.
  • Sarvat B, Sarria JC. 2007. Implantable cardioverter-defibrillator infection due to Scedosporium apiospermum. J Infect. 55:e109–e113.
  • Satirapoj B, Ruangkanchanasetr P, Treewatchareekorn S, Supasyndh O, Luesutthiviboon L, Supaporn T. 2008. Pseudallescheria boydii brain abscess in a renal transplant recipient: first case report in Southeast Asia. Transplant Proc. 40:2425–2427.
  • Sayah DM, Schwartz BS, Kukreja J, Singer JP, Golden JA, Leard LE. 2013. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis. Transpl Infect Dis. 15:E70–E74.
  • Schaenman JM, DiGiulio DB, Mirels LF, McClenny NM, Berry GJ, Fothergill AW, Rinaldi MG, Montoya JG. 2005. Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy. J Clin Microbiol. 43:973–977.
  • Schwartz S, Ruhnke M, Ribaud P, Corey L, Driscoll T, Cornely OA, Schuler U, Lutsar I, Troke P, Thiel E. 2005. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood. 106:2641–2645.
  • Seidel D, Durán Graeff L, Vehreschild MJGT, Wisplinghoff H, Ziegler M, Vehreschild JJ, Liss B, Hamprecht A, Köhler P, Racil Z, et al. 2017. FungiScope™ – Global Emerging Fungal Infection Registry. Mycoses. 60:508–516.
  • Shand JM, Albrecht RM, Burnett HF, 3rd, Miyake A. 2004. Invasive fungal infection of the midfacial and orbital complex due to Scedosporium apiospermum and mucormycosis. J Oral Maxillofac Surg. 62:231–234.
  • Shankar S, Biswas J, Gopal L, Bagyalakshmi R, Therese L, Borse NJ. 2007. Anterior chamber exudative mass due to Scedosporium apiospermum in an immunocompetent individual. Indian J Ophthalmol. 55:226–227.
  • Sharma A, Singh D. 2015. Scedosporium apiospermum causing brain abscess in a renal allograft recipient. Saudi J Kidney Dis Transpl. 26:1253–1256.
  • Sheu R, Bricker AO, Sahi H, Mohammed TL. 2009. Pseudallescheria boydii (Scedosporium species) in 3 lung transplant recipients: computed tomography findings and literature review. J Comput Assist Tomogr. 33:247–252.
  • Shimizu J, Yoshimoto M, Takebayashi T, Ida K, Tanimoto K, Yamashita T. 2014. Atypical fungal vertebral osteomyelitis in a tsunami survivor of the Great East Japan Earthquake. Spine (Phila Pa 1976). 39:E739–E742.
  • Shu T, Green JM, Orihuela E. 2004. Testicular involvement in disseminated fungal infection by Pseudallescheria boydii. Urology. 63:981–982.
  • Signore SC, Dohm CP, Schütze G, Bähr M, Kermer P. 2017. Scedosporium apiospermum brain abscesses in a patient after near-drowning - a case report with 10-year follow-up and a review of the literature. Med Mycol Case Rep. 17:17–19.
  • Singh RP, McCluskey P. 2005. Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C. Clin Experiment Ophthalmol. Ophthalmol. 33:433–434.
  • Sireesha P, Kumar CHM, Setty CR. 2010. Thyroid abscess due to Scedosporium apiospermum. Indian J Med Microbiol. 28:409–411.
  • Slone HW, Kontzialis M, Kiani B, Triola C, Oettel DJ, Bourekas EC. 2013. MRI with Magnetic Resonance Spectroscopy of multiple brain abscesses secondary to Scedosporium apiospermum in two immunocompromised patients. Clin Imaging. 37:361–366.
  • Smita S, Sunil S, Amarjeet K, Anil B, Yatin M. 2015. Surviving a recurrent Scedosporium prolificans endocarditis: mention if consent was taken. Indian J Med Microbiol. 33:588–590.
  • Solé A. 2011. Scedosporium apiospermum disseminated infection in a single lung transplant recipient. Rev Iberoam Micol. 28:139–142.
  • Spanevello M, Morris KL, Kennedy GA. 2010. Pseudoaneurysm formation by Scedosporium prolificans infection in acute leukaemia. Intern Med J. 40:793.
  • Stoneham AC, Stoneham SE, Wyllie SA, Pandya AN. 2017. Surgical resection of a rare cutaneous manifestation of Scedosporium apiospermum in a patient who underwent renal transplant. BMJ Case Rep. 2017:pii:bcr2016217923.
  • Strunk T, Blume JH, Szeimies RM. 2015. [Deep skin infection with Scedosporium apiospermum-infection in a renal transplant patient]. Hautarzt. 66:195–198.
  • Stur-Hofmann K, Stos S, Saxa-Enenkel M, Rappersberger K. 2011. Primary cutaneous infection with Scedosporium apiospermum successfully treated with voriconazole. Mycoses. 54:e201–e204.
  • Symoens F, Knoop C, Schrooyen M, Denis O, Estenne M, Nolard N, Jacobs F. 2006. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant. 25:603–607.
  • Takeuchi M, Yoshida C, Ota Y, Fujiwara Y. 2011. Deep skin infection of Scedosporium apiospermum in a patient with refractory idiopathic thrombocytopenic purpura. Intern Med. 50:1339–1343.
  • Talbot TR, Hatcher J, Davis SF, Pierson RN, 3rd, Barton R, Dummer S. 2002. Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient. Transplantation. 74:1645–1647.
  • Tamaki M, Nozaki K, Onishi M, Yamamoto K, Ujiie H, Sugahara H. 2016. Fungal meningitis caused by Lomentospora prolificans after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 18:601–605.
  • Tammer I, Tintelnot K, Braun-Dullaeus RC, Mawrin C, Scherlach C, Schluter D, Konig W. 2011. Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease-a diagnostic and therapeutic challenge. Int J Infect Dis. 15:e422–e429.
  • Tan TY, Liou CW, Kung LC. 2004. Meningitis caused by Pseudallescheria boydii. Chang Gung Med J. 27:228–232.
  • Tascini C, Bongiorni MG, Leonildi A, Giannola G, Soldati E, Arena G, Doria R, Germenia C, Menichetti F. 2006. Pacemaker endocarditis with pulmonary cavitary lesion due to Scedosporium prolificans. J Chemother. 18:667–669.
  • Taylor A, Wiffen SJ, Kennedy CJ. 2002. Post-traumatic Scedosporium inflatum endophthalmitis. Clin Experiment Ophthalmol. 30:47–48.
  • The European Committee on Antimicrobial Susceptibility Testing. 2017. EUCAST method for susceptibility testing of moulds (version 9.3.1 valid from 15 January, 2017). [accessed 2017 Sep 01]. http://www.eucast.org/ast_of_fungi/methodsinantifungalsusceptibilitytesting/susceptibility_testing_of_moulds/.
  • Thiagalingam S, Fernando GT, Tan K, O'Donnell BA, Weeks K, Branley M. 2004. Orbital apex syndrome secondary to Pseudallescheria boydii fungal sinusitis in an immunocompetent patient. Clin Exp Ophthalmol. 32:545–547.
  • Thomson S, Alibhai K, Winkelaar G, Lien D, Halloran K, Kapasi A, Weinkauf J. 2015. Case report of vertebral osteomyelitis and mycotic abdominal aortic aneurysm caused by Scedosporium apiospermum in a lung transplant patient with cystic fibrosis. Transplant Proc. 47:204–209.
  • Tietz H-J, Nennoff P, Ullmann AJ. 2005. Organmykosen auf einen Blick: Diagnostik und Therapie lebensbedrohlicher Pilzinfektionen. Thieme.
  • Tilakaratne D, Ryan E, Pearce A. 2016. Concurrent pyoderma gangrenosum and infection with Scedosporium apiospermum. Australas J Dermatol. 57:e46–e48.
  • Tintelnot K, Just-Nübling G, Horré R, Graf B, Sobottka I, Seibold M, Haas A, Kaben U, De Hoog GS. 2009. A review of German Scedosporium prolificans cases from 1993 to 2007. Med Mycol. 47:351–358.
  • Tirado-Miranda R, Solera-Santos J, Brasero JC, Haro-Estarriol M, Cascales-Sánchez P, Igualada JB. 2001. Septic arthritis due to Scedosporium apiospermum: case report and review. J Infect. 43:210–212.
  • Tong SY, Peleg AY, Yoong J, Handke R, Szer J, Slavin M. 2007. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient. Transplant Infect Dis. 9:241–243.
  • Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Muñoz P, Johnson E, Meletiadis J, Pana ZD, Lackner M, et al. 2014. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 20:27–46.
  • Tóth EJ, Nagy GR, Homa M, Ábrók M, Kiss IÉ, Nagy G, Bata-Csörgő Z, Kemény L, Urbán E, Vágvölgyi C, et al. 2017. Recurrent Scedosporium apiospermum mycetoma successfully treated by surgical excision and terbinafine treatment: a case report and review of the literature. Ann Clin Microbiol Antimicrob. 16:31.
  • Troke P, Aguirrebengoa K, Arteaga C, Ellis D, Heath CH, Lutsar I, Rovira M, Nguyen Q, Slavin M, Chen SC. 2008. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother. 52:1743–1750.
  • Trubiano JA, Paratz E, Wolf M, Teh BW, Todaro M, Thursky KA, Slavin MA. 2014. Disseminated Scedosporium prolificans infection in an ‘extensive metaboliser’: navigating the minefield of drug interactions and pharmacogenomics. Mycoses. 57:572–576.
  • Tsuji G, Takei K, Takahara M, Matsuda T, Nakahara T, Furue M, Uchi H. 2017. Cutaneous Pseudallescheria boydii/Scedosporium apiospermum complex infection in immunocompromised patients: a report of two cases. J Dermatol. 44:1067–1068.
  • Uenotsuchi T, Moroi Y, Urabe K, Tsuji G, Koga T, Matsuda T, Furue M. 2005. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient and a review of the literature. Acta Derm Venereol. 85:156–159.
  • Uno K, Kasahara K, Kutsuna S, Katanami Y, Yamamoto Y, Maeda K, Konishi M, Ogawa T, Yoneda T, Yoshida K, et al. 2014. Infective endocarditis and meningitis due to Scedosporium prolificans in a renal transplant recipient. J Infect Chemother. 20:131–133.
  • Vagefi MR, Kim ET, Alvarado RG, Duncan JL, Howes EL, Crawford JB. 2005. Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. Am J Ophthalmol. 139:370–373.
  • Verghese S, Padmaja P, Chellamma MT, Leelavathy S, Nayar P. 2005. Prosthetic valve endocarditis caused by Scedosporium apiospermum. Indian J Med Microbiol. 23:264–266.
  • Wang XY, Yu SL, Chen S, Zhang WH. 2016. CNS infection caused by Pseudallescheria boydii in a near-drowning traveller from a traffic accident. J Travel Med. 23:tav018.
  • Wiederhold NP, Law D, Birch M. 2017. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans. J Antimicrob Chemother. 72:1977–1980.
  • Williams JR, Tenforde MW, Chan JD, Ko A, Graham SM. 2016. Safety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection. Med Mycol Case Rep. 13:1–4.
  • Wilson HL, Kennedy KJ. 2013. Scedosporium apiospermum brain abscesses in an immunocompetent man with silicosis. Med Mycol Case Rep. 2:75–78.
  • Wu Z, Ying H, Yiu S, Irvine J, Smith R. 2002. Fungal keratitis caused by Scedosporium apiospermum: report of two cases and review of treatment. Cornea. 21:519–523.
  • Yoneda K, Nakai K, Moriue T, Ishikawa E, Demitsu T, Ohkusu K, Kubota Y. 2012. Scedosporium apiospermum skin infection mimicking tuberous xanthoma. J Dermatol. 39:316–318.
  • Yu Z, Hu L, Jiang M, Ning H, Xu C, Li B, Li Y, Lou X, Wang J, Hu J, et al. 2013. Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation. Intern Med. 52:689–693.
  • Zaas D. 2002. Cases from the Osler medical service at Johns Hopkins University. Scedosporium apiospermum mycetoma of the lung. Am J Med. 113:760–762.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.